Literature DB >> 27128615

Pharmacokinetic bioequivalence crossover study of branded generic and innovator formulations of the cholesterol lowering agent ezetimibe.

Jonathan L Palmer1, Anil Kunhihitlu2, Andrea Costantini3, Florencia Esquivel3, John Roush4, Karina Edwards5, Thomas W K Hill6.   

Abstract

Entities:  

Keywords:  bioequivalence; branded generic; ezetimibe; innovator

Mesh：

Substances：

Year:  2014        PMID： 27128615     DOI： 10.1002/cpdd.80

Source DB:  PubMed          Journal:  Clin Pharmacol Drug Dev        ISSN： 2160-763X


× No keyword cloud information.
  2 in total

Review 1.  Generic versus brand-name drugs used in cardiovascular diseases.

Authors:  Lamberto Manzoli; Maria Elena Flacco; Stefania Boccia; Elvira D'Andrea; Nikola Panic; Carolina Marzuillo; Roberta Siliquini; Walter Ricciardi; Paolo Villari; John P A Ioannidis
Journal:  Eur J Epidemiol       Date:  2015-11-30       Impact factor: 8.082

2.  Prescription writing: Generic or brand?

Authors:  Chittaranjan Andrade; T S Sathyanarayana Rao
Journal:  Indian J Psychiatry       Date:  2017 Apr-Jun       Impact factor: 1.759
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.